None
Quote | Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)
Last: | $2.19 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $2.19 |
High: | $0 |
Low: | $0 |
Volume: | 800 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)
WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced ...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”) at a price of $2.20 per share, net to the s...
Message Board Posts | Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)
Subject | By | Source | When |
---|---|---|---|
Yes...keep an eye on this for a later | Pedro2004 | investorshub | 10/19/2021 2:30:34 PM |
Ok that explains the $1 dollar fall from | swampboots | investorshub | 10/19/2021 1:58:35 PM |
We have entered into an Controlled Equity Offering | Pedro2004 | investorshub | 10/19/2021 1:09:33 PM |
$ETTX $+ data confirms, what is addressable market? | swampboots | investorshub | 10/18/2021 8:39:15 PM |
New reddit group talking only about $ETTX. | frugalNorwegian | investorshub | 08/20/2021 8:37:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Entasis Therapeutics Holdings Inc. Company Name:
ETTX Stock Symbol:
NASDAQ Market:
Entasis Therapeutics Holdings Inc. Website:
WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced ...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”) at a price of $2.20 per share, net to the s...
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations at the American Society...